About Evelo Biosciences
Evelo Biosciences is a company based in Cambridge (United States) founded in 2015.. Evelo Biosciences has raised $166.5 million across 4 funding rounds from investors including Flagship Pioneering, Celgene and Google Ventures. Evelo Biosciences has completed 1 acquisition, including Epiva Therapeutics. Evelo Biosciences operates in a competitive market with competitors including Ironwood Pharma, RedHill Biopharma, Alcresta, Seed and Ardelyx, among others.
- Headquarter Cambridge, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Evelo Biosciences, Inc.
-
Annual Revenue
$00as on Dec 31, 2022
-
Net Profit
$-114.53 M6.26as on Dec 31, 2022
-
EBITDA
$-103.51 M7.03as on Dec 31, 2022
-
Total Equity Funding
$166.5 M (USD)
in 4 rounds
-
Latest Funding Round
$25.5 M (USD), Post-IPO
Jul 10, 2023
-
Investors
Flagship Pioneering
& 4 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Evelo Biosciences
Evelo Biosciences is a publicly listed company on the OTC with ticker symbol EVLO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Funding Insights of Evelo Biosciences
Evelo Biosciences has successfully raised a total of $166.5M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $25.5 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $25.5M
-
First Round
First Round
(04 Nov 2015)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2023 | Amount | Post-IPO - Evelo Biosciences | Valuation |
investors |
|
| Mar, 2018 | Amount | Series C - Evelo Biosciences | Valuation |
investors |
|
| Jul, 2017 | Amount | Series B - Evelo Biosciences | Valuation | Flagship Pioneering , Google Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Evelo Biosciences
Evelo Biosciences has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Flagship Pioneering, Celgene and Google Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life sciences-focused venture capital firm
|
Founded Year | Domain | Location | |
|
Corporate backed venture capital fund investing in multiple sectors
|
Founded Year | Domain | Location | |
|
Early stage investments focused VC firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Evelo Biosciences
Evelo Biosciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Epiva Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Microbiome-based therapeutics are developed for autoimmune diseases.
|
2015 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Evelo Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Evelo Biosciences Comparisons
Competitors of Evelo Biosciences
Evelo Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ironwood Pharma, RedHill Biopharma, Alcresta, Seed and Ardelyx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases
|
|
| domain | founded_year | HQ Location |
Enzyme-based products for gastrointestinal disorders are developed using immobilization technology.
|
|
| domain | founded_year | HQ Location |
Synbiotics are developed for simulating the gut microbiome.
|
|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Evelo Biosciences
Frequently Asked Questions about Evelo Biosciences
When was Evelo Biosciences founded?
Evelo Biosciences was founded in 2015.
Where is Evelo Biosciences located?
Evelo Biosciences is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Who is the current CEO of Evelo Biosciences?
Simba Gill is the current CEO of Evelo Biosciences.
Is Evelo Biosciences a funded company?
Evelo Biosciences is a funded company, having raised a total of $166.5M across 4 funding rounds to date. The company's 1st funding round was a Series B of $50M, raised on Nov 04, 2015.
What does Evelo Biosciences do?
Developer of therapeutics to treat a range of inflammatory diseases, COVID-19, and cancer. The company focuses on discovering and developing a new class of orally delivered medicines to modulate the immune system through SINTAX, the small intestinal axis. The product pipeline inlcudes EDP1815, EDP1867 and EDP2939 for the treatment of inflammatory diseases, and EDP1908 for the treatment of cancer.
Who are the top competitors of Evelo Biosciences?
Evelo Biosciences's top competitors include Ironwood Pharma, Ardelyx and RedHill Biopharma.
Is Evelo Biosciences publicly traded?
Yes, Evelo Biosciences is publicly traded on OTC under the ticker symbol EVLO.
How many acquisitions has Evelo Biosciences made?
Evelo Biosciences has made 1 acquisition, including Epiva Therapeutics.
Who are Evelo Biosciences's investors?
Evelo Biosciences has 5 investors. Key investors include Flagship Pioneering, Celgene, Google Ventures, Acks, and Mayo Clinic Ventures.
What is Evelo Biosciences's ticker symbol?
The ticker symbol of Evelo Biosciences is EVLO on OTC.